期刊
FEBS LETTERS
卷 584, 期 19, 页码 4259-4267出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2010.09.022
关键词
Alzheimer's disease; Estrogen; Amyloid precursor protein; Phosphoinositide 3-kinase; Furin; Epigallocatechin gallate; A disintegrin and metalloprotease domain 10
资金
- NCAAM [R43AT004871]
- NIA [R43AG033417]
- Veterans Affairs
Estrogen depletion following menopause has been correlated with an increased risk of developing Alzheimer's disease (AD). We previously explored the beneficial effect of (-)-epigallocatechin-3-gallate (EGCG) on AD mice and found increased non-amyloidogenic processing of amyloid precursor protein (APP) through the alpha-secretase a disintegrin and metallopeptidase domain 10 (ADAM10). Our results in this study suggest that EGCG-mediated enhancement of non-amyloidogenic processing of APP is mediated by the maturation of ADAM10 via an estrogen receptor-alpha (ER alpha)/phosphoinositide 3-kinase/Ak-transforming dependent mechanism, independent of furin-mediated ADAM10 activation. These data support prior assertions that central selective ER modulation could be a therapeutic target for AD and support the use of EGCG as a well-tolerated alternative to estrogen therapy in the prophylaxis and treatment of this disease. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据